CP-70949

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameCP-70949
Drug Alias NameGSK-3-beta inhibitor (Pfizer)glycogen synthase kinase-3-beta inhibitor (Pfizer)PFI-367PFI-856CP-70949
ClassificationSmall molecules
Mechanisms of ActionNeuroprotectantsGlycogen synthase kinase-3 beta inhibitors
TargetsGlycogen synthase kinase-3 beta
Therapy Area/IndicationsNerve DegenerationDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsNerve DegenerationDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A